MNS

0.00%

4.2¢ magnis energy technologies ltd

Director Salaries, page-80

First 80 Last

Bullish Event

3,780 Posts.

161

22/10/18

07:36

Post #: 36205069

Originally posted by Riskon22 ↑

@spid81 Would you rather have 10 or 4 directors working to advance your companies global scale projects???

Magnis has far more directors that its peers working to further company interests. When comparing and calling for remuneration reviews, I would have thought it only logical to include such an important fact.

Actually, on individual basis, Magnis directors are paid far less than their peers:

Column 1 Column 2 Column 3 Column 4

1 To. director renum. No. of directors Avg. director salary

2 Magnis 1,440,281 10 144,028

3 Volt 1,169,153 7 167,022

4 Walkabout 1,208,063 4 302,016

5 Kibaran 2,921,456 6 486,909

To be honest, if I was a director, I would rather work for Kibaran, and get paid 3 times the amount than if I were to work at Magnis. But then again, with the ATO querying R&D claims and capital raises for less than director yearly remuneration amounts, imo Kibaran directors might not have a job in a year's time.

The SP will always have its ups and downs - look back 4 years, and Magnis has outperformed many of its peers. As a medium to long term holder, I'm interested in where the SP will be 3 years from now, and with gigafactories producing cheaper and better performing batteries coming online, I think the future is very, very bright

Expand

Imo,You’re a wealth of experienced information,i wouldn’t be bothered with any sell/non holder comments on this forum after reading your logic.
10 directors working for the success of the company at minimum salary for a further couple of years is promising
Thanks for your contributions.

MNS Price at posting: 29.5¢ Sentiment: Buy Disclosure: Held

2 Upvote

0 Great analysis

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

HotCopper Highlights: Your most watched stocks for Week 48, 2024

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 20 more messages in this thread...

First 80 Last

Add MNS (ASX) to my watchlist

(20min delay)
Last 4.2¢		Change 0.000(0.00%)		Mkt cap ! $50.37M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

MNS (ASX) Chart

Day chart unavailable

	Column 1	Column 2	Column 3	Column 4
1		To. director renum.	No. of directors	Avg. director salary
2	Magnis	1,440,281	10	144,028
3	Volt	1,169,153	7	167,022
4	Walkabout	1,208,063	4	302,016
5	Kibaran	2,921,456	6	486,909

Director Salaries, page-80

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

HotCopper Highlights: Your most watched stocks for Week 48, 2024

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game